In this report, we found that MLT substantially reduces AML1‐ETO protein in leukaemia cell lines, primary AML blasts, and AML1‐ETO‐induced murine leukaemia blasts. The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.